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ABSTRACT
Objectives: To analyze the correlation between ultrasound typing and treatment modality of patients with an intrauterine 
ectopic pregnancy (cervical and cesarean scar).
Material and methods: We retrospectively enrolled 65 patients diagnosed with cesarean scar pregnancy (CSP) or cervical 
pregnancy (CP) between February 2014 and May 2018. The cases were divided into two types according to the ultrasound 
presentation with a gestational sac (GS, type I) or a heterogeneous mass (HM, type II). Type I was further divided into type 
Ia (< 8 weeks) and type Ib (≥ 8 weeks); type II was defined as type IIa (with poor or no vascularity) and type IIb (with rich 
vascularity). Three treatment methods were applied in each group. 
Results: Of included cases, there were 53 CSP and 12 CP. There was no significant difference between Type I and Type 
II groups in any variable. The beta human chorionic gonadotropin (β-hCG) level and gestational age of type IIb were 
significantly higher compared to type IIa (p < 0.05). There was a positive correlation between ultrasound categories and 
treatment methods (rs = 0.723, p = 0.000). Analysis of CSP cases of initial treatment failure indicated success rate of initial 
dilation and curettage (D&C) was dependent upon ultrasonic types, mean sac diameter, gestational age, hCG level, and 
number of cesarean sections.
Conclusions: The features of ultrasound imaging might provide an additional reference for the selection of clinical treat-
ment methods. 
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INTRODUCTION
Cesarean scar pregnancy (CSP) and cervical pregnancy 
(CP) are relatively rare and unusual types of ectopic implan-
tations in the lower segment of the uterus. They are defined 
as pregnancies that implant within the uterus, but outside 
the uterine cavity [1, 2].
Cesarean scar pregnancy occurs when a gestational 
sac implants at the site of a previous cesarean section. 
With the recent change in China’s One-Child Policy to 
a Two-Child Policy, the incidence and detection rate of 
CSP are rising. Cesarean scar pregnancy incidence has 
increased from 1 per 2,226 to 1 per 1,800 pregnancies 
[3], along with an increased rate of cesarean sections 
and increased knowledge and awareness of diagnostic 
ultrasound. 
In the case of CP, the conceptus implants in the en-
docervical canal below the internal os. Cervical pregnancy 
occurs in less than 1% of all pregnancies, or 1 in 1,000 to 
1 in 18,000 pregnancies [4]. The first case was reported in 
1978 [5], and its risk factors have not been clearly elucidated. 
The clinical symptoms of CP and CSP are similar [6]. 
Initially, patients may have no distinctive clinical presenta-
tion and often have mild vaginal bleeding, with or without 
vague abdominal pain. As pregnancy progresses, the risk of 
unexpected life-threatening hemorrhage or uterine rupture 
escalates due to the erosion of cervical blood vessels and 
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invasion of the myometrium early in the first trimester [7]. 
On that account, timely diagnosis and individualized man-
agement are critical for reducing morbidity and mortality. 
However, differentiating between CSP, CP, and threat-
ened miscarriage via diagnostic ultrasound in a low-lying 
gestation sac is particularly difficult [8–10]. Not all cases of 
CSP and CP present with typical ultrasonic imaging [8]. Ec-
topic pregnancies are often accompanied by a hypoechoic 
mass in the lower uterine segment [11–14]. Hypoechoic 
masses are atypical and are sometimes misdiagnosed as 
anterior myometrial fibroids or trophoblastic tumors [7, 8]. 
At present, previous studies have mainly focused only on 
the gestational sac, and there is very little data on the hy-
poechoic mass on ultrasound findings as well as its proper 
management [11, 15].
In this report, we present an analysis of ultrasound find-
ings and treatment strategy for patients diagnosed with 
CSP or CP at our institution during a 4-year period and to 
discuss the relationship between ultrasonography typing 
and treatment modality.
MATERIAL AND METHODS
This study was approved by our Institutional Review Board 
of Research Ethics Committee. Informed consent was ob-
tained from all patients before they were enrolled in the study. 
We retrospectively included cases of CSP and CP at the Affili-
ated Ethnic Hospital of Guangxi Medical University from May 
2014 to November 2018. Transvaginal and transabdominal ul-
trasound examinations were performed with an iU22 (Philips 
Electronics NV, Netherlands) or Hitachi EUB 6000 (Tokyo, Ja-
pan) ultrasound. The inclusion criterion for the study was 
the diagnosis of CP or CSP who were initially treated at our 
hospital. The exclusion criteria comprised the cases of CP or 
CSP who were initially taken an attempted curettage with fail-
ure in local clinics or community hospitals and subsequently 
transferred to our hospital, as well as abortion, heterotopic 
pregnancy and cornual pregnancies. The final diagnoses were 
established by histopathology or operative findings and were 
confirmed by clinical follow-up. A clinical database was com-
piled from information in electronic medical records including 
patient age, gestational age, β-hCG level at the time of primary 
diagnosis, initial and additional treatment. 
Sonographic classification of CSP and CP
In this study, the diagnosis of CSP and CP were based 
on ultrasound criteria reported on the literature [1, 7–9, 12]. 
All cases were divided into two types according to the ultra-
sound presentation with a gestational sac (type I) or a hetero-
geneous mass (type II). Then, each group was further divided 
into two subtypes based on gestational age or vascularity 
within the mass. As previously reported [16–18], the gesta-
tional age of 8 weeks is regarded as the dividing line. The 
treatment of gestational sac ≥ 8 weeks is different from the 
ones less than 8 weeks. Consequently, type Ia could be de-
fined as a GS at > 8 weeks and type Ib represented a GS shape 
at ≥ 8 weeks gestation. Similarly, type IIa indicated a hetero-
geneous mass was highly suspected to be an ectopic preg-
nancy in the lower uterine segment present with poor or no 
vascularity on color Doppler ultrasound imaging, and type 
IIb implied the heterogeneous mass in a high index of suspi-
cion had rich vascularity by color Doppler ultrasound (Fig. 1). 
Two experienced radiologists (F.Y.J. and H.Q.S.) were blinded 
to study variables and independently categorized cases; 
inter-rater agreement was 100%.
Treatment modalities for CSP and CP
Although many management options have been pro-
posed, there is no consensus on the preferred mode of 
treatment for CSP or CP. The treatment strategies remain 
highly varied [19]. Three therapeutic methods were ap-
plied as initial treatment in this study. The first method, 
D&C, was suitable for hemodynamically stable (minimal 
blood loss) cases of endogenous CSP and asymptomatic CP 
at < 8 weeks of gestation. This method was combined with 
adjuvant therapy such as oral mifepristone or injection of 
methotrexate (MTX) and often performed under ultrasound 
guidance. The second method, hysteroscopic resection (HR), 
was often combined with additional hemostatic measures, 
for instance, cervical cerclage, balloon tamponade, and local 
injection of MTX. This treatment method was most regularly 
used in CP cases. Also, it was adapted for endogenous CSP 
patients who declined D&C treatment. The third method, 
surgical resection (SR), was performed by laparoscopy, 
hysterotomy, or hysterectomy to cut out gestational tis-
sues. Surgical resection was suitable for all the cases of CSP 
or CP with severe symptoms like hemodynamic instability, 
Figure 1. The description of our new ultrasound types for CSP and 
CP; Type Ia was defined as an early gestational sac (< 8 weeks); Type 
Ib represented a GS shape at ≥ 8 weeks gestation; Type IIa indicated 
a heterogeneous mass without vascular pattern; Type IIb implied 
a heterogeneous mass with rich trophoblastic circulation, partly 
generating an arteriovenous fistula
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uterine rupture, or placental implantation abnormalities, 
as well as the cases of exogenous CSP. Surgical resection 
was occasionally combined with hysteroscopy and local 
injection of MTX. As previously mentioned, strict treatment 
guidelines did not exist for clinical management.
Statistical analysis
Statistical analysis was performed using SPSS version 
22.0 (Chicago, IL, USA). Quantitative data was presented 
as mean ± standard deviation or frequency (%). The cor-
relation between ultrasound types and treatment methods 
were calculated by Spearman correlation. One-way analysis 
of variance (ANOVA), Student t test and Fisher’s exact test 
were used to compare group characteristics and treatment 
methods. Statistical significance was defined as p < 0.05.
RESULTS
During the 4-year period, a total of 74 patients with 
CSP and CP were hospitalized at our hospital. Nine patients 
were (eight patients with CSP, one patient with CP) excluded 
from this study on account of their initial treatment failed 
at other hospitals. Ultimately, in the ectopic pregnancies 
enrolled, there were 53 CSP and 12 CP. The mean patient 
age of CSP cases was 33.30 ± 4.05 years and the gestational 
age was 4–10 weeks. The mean age of CP patients was 
31.00 ± 5.75 years and the gestational age was 4–9 weeks. 
Ultrasound findings
The ultrasound examination revealed that 45 patients 
presented with a gestational sac (69.2%, 45/65) and 20 pa-
tients presented with a heterogeneous mass (30.8%, 20/65). 
The numbers of patients categorized as type Ia, Ib, IIa, and IIb 
were 32, 13, 7, and 13, respectively. The detailed distribution 
is shown in Figure 2 and Figure 3. 
No statistical difference was found between type I and 
type II groups with respect to patient age, β-hCG level, 
mean sac diameter, and gestational age at diagnosis. When 
ultrasonography both manifested a heterogeneous mass 
(type II), the average β-hCG level and gestational age of 
type IIb patients were significantly higher compared to 
type IIa cases (Tab. 1).
Comparison of treatment modalities between 
CSP and CP
In general, the initial treatment methods utilized in this 
study were D&C (n = 31, 47.7%), hysteroscopic resection 
CSP: 53
GS: 35
Type Ia: 25 Type Ib: 10
D&C: 25 D&C: 4 HR: 3 SR: 3
HR: 1 SR: 2 SR: 2 HR: 2 SR: 1
HR: 5 SR: 1 SR: 6 hR: 6
HM: 18
Type IIa: 6 Type IIb: 12
CP: 12
GS: 10 HM: 2
Type Ia: 7 Type Ib: 3 Type IIa: 1 Type Iib: 1
D&C: 2 HR: 5
HR: 1
HR: 3 HR: 1 HR: 1
Figure 2. Ultrasound classification and treatment options for cervical 
pregnancy (CP); GS — gestational sac; HM — heterogeneous mass; 
D&C — dilation and curettage; HR — hysteroscopic resection; Only 
one patient performed additional treatment
Figure 3. Ultrasound classification and treatment options for cesarean scar pregnancy (CSP); GS — gestational sac; HM — heterogeneous mass; 
D&C — dilation and curettage; HR — hysteroscopic resection; SR — surgical resection; There were 8 patients performed additional treatment
Table 1. Comparison of preoperative conditions between two 
ultrasound subtypes
Type IIa Type IIb p
Patient age [y] 30.60 ± 4.775 33.89 ± 3.333 0.154
Gestational weeks 5.50 ± 1.456 8.033 ± 0.893 0.002
Initial hCG level 
[milliunits/mL] 6841.20 ± 3259.18 31577.4 ± 21902.77 0.030
Gestational sac 
size [mm] 31.60 ± 9.127 41.16 ± 11.89 0.154
Data are mean ± SD; hCG, — human chorionic gonadotropin;  
Type IIa — a heterogeneous mass present with poor or no vascularity;  
Type IIb — a heterogeneous mass present with rich vascularity
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(n = 24, 36.9%), and surgical resection (n = 10, 15.4%). Cervical 
pregnancies were mainly treated by hysteroscopic resection 
(n = 10, 83.3%), D&C (n = 2, 16.7%) (Fig. 2). Cesarean scar 
pregnancies were primarily treated by D&C (n = 29, 54.7%), 
hysteroscopic resection (n = 14, 26.4%) and surgical resection 
(n = 10, 18.9%) (Fig. 3). The success rate of initial treatment was 
91.7% for CP patients and 84.9% for CSP patients. The total 
number of cases after initial treatment failed was 9, including 
1 CP and 8 CSP. Among of these failed cases, 8 patients were 
originally performed by D&C treatment, which were 1 CP 
and 7 CSP respectively. A closer analysis of CSP failed cases 
revealed that successful treatment by D&C was dependent 
upon the ultrasound types, mean sac diameter, gestational 
age, β-hCG level, and number of cesarean sections (Tab. 2).
Comparing the three different treatment modalities 
of the ectopic pregnancy located in the lower segment of 
the uterus, the gestational age, mean sac diameter, and 
β-hCG level of patients undergoing surgical resection were 
significantly higher than those of patients undergoing D&C 
and hysteroscopic resection (Tab. 3). By contrast, the cases 
of D&C were all patients present with a gestational sac on 
ultrasonic imaging, along with smaller gestational age, 
mean sac diameter and lower β-hCG levels than the oth-
ers. Spearman correlation showed that ultrasound clas-
sification was highly correlated with treatment method 
(rs = 0.723, p = 0.000). The average patient age did not have 
significant differences among treatment modalities (Tab. 3).
DISCUSSION
It is well known that ultrasonography plays a central 
role in the diagnosis of ectopic pregnancies [20, 21]. In this 
study, there was a notable characteristics of ultrasound find-
ings. A proportion of enrolled cases (30.8%) were shown het-
erogeneous masses upon ultrasound examination, which 
had less been previously reported in the literature.   
Generally, the presence of an echogenic mass may in-
dicate a different status of conception compared to a GS. 
It may or may not show vascularity at color Doppler US cor-
responding to its state, which may be related to the level 
of β-hCG [13]. Our data indicated the amount of vascularity 
(type IIa: poor vascularity, type IIb: rich vascularity) was cor-
related with β-hCG level and gestational age (p = 0.030 and 
p = 0.002, respectively). Type IIb cases presented rich vascu-
larity surrounding a gestational trophoblastic mass. Three of 
these patients (1 CP, 2 CSP) were found arteriovenous malfor-
mations within the mass, which were easily misinterpreted 
as trophoblastic tumors. These observations implied that 
this type of mass may be an active trophoblastic tissue [13]. 
Conversely, our study revealed that ultrasound evidence of 
an avascular hypoechoic mass indicated that it was be either 
a degeneration of the conceptus whose serum β-hCG levels 
had reduced, or an subchorionic hematoma. These were 
consistent with surgical results.
Moreover, our data indicated a high association between 
ultrasound findings and treatment modalities in the first 
Table 2. Comparison of preoperative conditions between successful and failed treatments of CSP by dilation and curettage
Success Failure p
Patient age [y] 33.0 ± 3.57 32.67 ± 5.28 0.875
Gestational weeks 6.33 ± 0.741 7.767 ± 1.041 0.004
Initial hCG level [milliunits/mL] 15379.17 ± 9920.198 56322.33 ± 26271.802 0.000
Gestational sac size [mm] 13.633 ± 3.671 28.717 ± 9.567 0.000
Number of CS 1.083 ± 0.289 1.667 ± 0.516 0.007
Type Ia 22 3
0.001*
Type Ib 0 4
CSP — cesarean scar pregnancy; hCG — human chorionic gonadotropin; CS — cesarean sections; Data are mean ± SD, n; * — Fisher’s exact test
Table 3. Comparison of preoperative conditions in three different treatment methods
Dilation and curettage Hysteroscopic resection Surgical resection
Patient age [y] 33.33 ± 4.304 (A1) 31.63 ± 5.679 (A2) 34.80 ± 1.924 (A3)
Gestational weeks 6.69 ± 1.149 (B1) 7.01 ± 1.695 (B2) 8.53 ± 0.612 (B3)
Initial hCG level [milliunits/mL] 28418.45 ± 24481.593 (C1) 18073.79 ± 15377.408 (C2) 46589.17 ± 23771.756 (C3)
Gestational sac size [mm] 18.705 ± 9.109 (D1) 29.484 ± 10.175 (D2) 46.883 ± 9.156 (D3)
Data are mean ± SD; Comparisons of patient age have no statistical difference: A1 vs A2, p = 0.319; A1 vs A3, p = 0.564; A2 vs A3, p = 0.204; The gestational weeks 
indicates a significant difference among the three groups: B1 vs B2, p = 0.469; B1 vs B3, p = 0.006; B2 vs B3, p = 0.022; Initial β-hCG level indicates a significant difference 
among the three groups: C1 vs C2, p = 0.131; C1 vs C3, p = 0.070; C2 vs C3, p = 0.006; Sac size indicates a significant difference among the three groups: D1 vs D2, 
p = 0.001; D1 vs D3, p = 0.000; D2 vs D3, p = 0.000
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trimester. All of the cases firstly treated by D&C were shown 
a gestational sac on ultrasound findings while the patients’ 
presence of a heterogeneous mass suggested to better 
initially treat with a more complex surgical procedure. This 
was different from the pervious studies [2, 12, 22]. In majority 
of reported cases, the selection of treatment modality was 
based on severity of symptoms, preoperative β-hCG levels, 
and the individual physician’s preference and expertise in 
order to minimize possible effect on future fertile capability 
of the patient [18]. There was scant data on the correlation 
between ultrasound findings and treatment methods in the 
available literature. 
At present, there were no consensual protocols for the 
treatment of CP and CSP. The management strategies of CP 
and CSP were somewhat different. Most patients with CP 
were performed by hysteroscopic resection in combination 
with adjuvant hemostatic techniques including balloon 
tamponade, cervical cerclage, and local injection of MTX. 
The primary management of CSP cases was D&C and the 
second was hysteroscopic resection. Surgical approach was 
performed in only 10 patients with CSP. No patient with CP 
required a surgical resection. 
In the present study, D&C was the primary treatment. 
Although it was performed in many cases (n = 31, CSP: 54.7%, 
CP: 16.7%) due to its shorter operation time, shorter hospi-
tal stay, and lower hospital cost compared to other thera-
peutic approaches [23], the initially unsuccessful treatment 
was most commonly managed with D&C [24]. Our data 
showed that 88.9% (8/9) of failed cases were performed by 
D&C. Particularly among them, 87.5% (7/8) of cases were 
CSP. This might be a factor that the success rate of initial 
treatment of CP was superior to CSP (91.7% vs 84.9%). It 
was well-known that there were 2 types of CSP, with type 
1 growing toward the uterine cavity and type 2 progress-
ing toward the bladder and abdominal cavity [23]. D&C 
treatment was ideal for type 1 CSP (endogenous CSP) to 
completely remove the abnormally adherent trophoblastic 
implantation. Unfortunately, type 2 CSP (exogenous CSP) 
with growth toward the bladder and abdominal cavity 
cannot be easily treated by D&C [24]. It may be difficult to 
scrape the gestational tissue products completely because 
of the invasion of the myometrium and erosion of bladder 
early in the first trimester, which would result in the high 
risk of a hemorrhagic event and uterine rupture. Further-
more, we found that the patients with type Ia (< 8 weeks) 
were more suitable for initial D&C treatment than type Ib 
(≥ 8 weeks). All of type Ib cases were applied additional 
treatment after performed D&C. In addition, the current 
study revealed that larger gestational sac, higher β-hCG 
level, and more numbers of previous cesarean sections 
may increase the risk of D&C treatment failure. An earlier 
gestational age would likely improve D&C success rate. 
This study had some limitations. Firstly, one notable 
limitation was retrospective nature. This influences the 
way in which medical data was collected and have conse-
quently included biases as unrecognized or unmeasured 
factors. Secondly, 9 patients with diagnosis of CP or CSP 
failed by D&C treatment at other hospitals were excluded 
from our analysis as an attempted curettage often alters the 
typical ultrasound findings, which may have an effected our 
results. Thirdly, this study mainly summarizes the ultimate 
therapeutic outcomes of these patients, without detailed 
comparison of some relevant clinical data, such as operation 
time, hospital stay, and hospital cost, and hospitalization 
cost. Finally, this was a small-sized, single center study.
In summary, the features of ultrasound imaging may 
provide an additional reference for the selection of clinical 
treatment methods. In a high degree of suspicion of intrau-
terine ectopic pregnancy in the lower segment of the uterus, 
the patients with a gestational sac less than 8 weeks on 
ultrasound imaging could be initially treated by D&C treat-
ment while women with a heterogeneous mass in a high 
degree of suspicion may be better treated with a more com-
plex surgical procedure. Future prospective and large-scale 
studies are warranted to validate this finding.
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